|
196 |
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo controlled trial. |
VITATOPS Trial Study Group, Xavier D, Pais P, et al; |
Lancet Neurol. |
2010 |
|
197 |
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. |
O'Donnell MJ, Xavier D, Liu L, Yusuf S, Pais P, et al; |
Lancet |
2010 |
|
198 |
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. |
FUTURA/OASIS-8 Trial Group, Mehta SR, Afzal R, Xavier D, Pogue J, Yusuf S, et al; |
JAMA 2010 |
2010 |
|
199 |
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. |
Diener HC, Connolly SJ, Xavier D, Yusuf S, et al; |
Lancet Neurol. |
2010 |
|
200 |
Dabigatran versus warfarin in patients with atrial fibrillation. |
Connolly SJ, Ezekowitz MD, Yusuf S, Alings M, Xavier D, et al; |
N Engl J Med. |
2009 |
|
201 |
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. |
Yusuf S, Pais P, Xavier D, Sigamani A, Mohan V, Gupta R, Thomas N, et al; |
Lancet |
2009 |
|
202 |
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. |
Goyal A, Mehta SR, Xavier D, Pais P, Yusuf S, et al; |
Am Heart J. |
2009 |
|
203 |
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. |
Goyal A, Mehta SR, Díaz R, Xavier D, Pais P, Yusuf S, et al; |
Circulation |
2009 |
|
204 |
The need to test the theories behind the Polypill: rationale behind the Indian Polycap |
*Xavier D*, *Pais P*, Sigamani A, Pogue J, Afzal R, Yusuf S; Indian Polycap Study (TIPS) Investigators |
Nat Clin Pract Cardiovasc Med |
2009 |
|
205 |
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy |
Mehta SR, Bassand JP, , Yusuf S; CURRENT-OASIS 7 Steering Committee |
Am Heart Journal |
2008 |
|
206 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. |
Sacco RL, Diener HC, Yusuf S, Pais P et al; |
N Engl J Med. |
2008 |
|
207 |
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. |
Oldgren J, Wallentin L, Afzal R, Pais P, Xavier D, Yusuf S, et al; |
Eur Heart J. |
2008 |
|
208 |
Telmisartan to prevent recurrent stroke and cardiovascular events. |
Yusuf S, Diener, Pais P, et al; |
N Engl J Med. |
2008 |
|
209 |
Polypharmacotherapy for primary prevention of cardiovascular disease. |
Xavier D, Devereaux PJ, Pais P, Yusuf S. |
Indian Heart J. |
2008 |
|
210 |
Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaem |
Diener HC, Sacco RL, Yusuf S, Pais P et al; |
Lancet Neurol. |
2008 |